BioCentury
ARTICLE | Clinical News

TPI 287: Additional Phase I/II data

December 7, 2015 8:00 AM UTC

Data from 20 evaluable patients with recurrent GBM who progressed following prior treatment with radiation and temozolomide in the open-label, dose-escalation, U.S. Phase I/II Study CB-017 showed that...